Ostroleka, Poland Clinical Trials
A listing of Ostroleka, Poland clinical trials actively recruiting patients volunteers.
Found 49 clinical trials
Savonix Inc-Alzheimer’s Disease Discovery
This study is looking for adults over the age of 22. This is an online cognitive study.Click the link below for more information:https://www.assiststudy.org/
- 692 views
- 23 Sep, 2022
- 1 location
- Online study
Web-Based Assessment Validation and Engagement Study
This study is looking for people who are over the age of 55 and have mild cognitive impairment or dementia. The study is also looking for people with normal cognition, as a comparison. The study is investigating a new computerized assessment.
- 1745 views
- 23 Sep, 2022
- 1 location
- Online study
Promoting Reengagement in Daily Meaningful Activity Intervention for adults with mild cognitive impairment and their caregivers
The PRIMA project is design to help persons with mild cognitive impairment to help them to improve their engagement in personally meaningful activity and improve their overall quality of life with their family caregivers support. The goal of PRIMA project is to increase persons with mild cognitive impairment’s engagement in …
- 439 views
- 23 Sep, 2022
- 1 location
- Online study
Alzheimer's Disease Center Research Registry
This study is looking for people over the age of 55 who have normal cognition, memory problems, or mild dementia. The study is also looking for people who are care partners of someone who has dementia. The study is intended to match people with studies that may be a good …
- 428 views
- 23 Sep, 2022
- 1 location
- Online study
Objective, Passive Assessment of LRRK2 Carriers (OPAL)
This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …
- 64 views
- 12 May, 2022
- 1 location
- Online study
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Patients With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer
This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with endocrine therapy of physician's choice in participants with medium- and high-risk Stage I-III histologically confirmed estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative early breast cancer.
- 21 views
- 15 Oct, 2022
- +653 other locations
A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) (VICTORION-2P)
Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).
- 1 views
- 10 Oct, 2022
- +661 other locations
![Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-Small Cell Lung Cancer Who Have Progressed on Prior Anti- Programmed Death-ligand 1 (PD-[L]1) Therapy and Chemotherapy](/media/imagery/261168.svg)
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-Small Cell Lung Cancer Who Have Progressed on Prior Anti- Programmed Death-ligand 1 (PD-[L]1) Therapy and Chemotherapy (COSTAR Lung)
This is a multi-center, parallel group treatment, Phase 2 open label study evaluating cobolimab in combination with dostarlimab and docetaxel in participants with advanced Non-small cell Lung Cancer (NSCLC) who have progressed on prior anti-PD-(L)1 therapy and chemotherapy.
- 14 views
- 04 May, 2022
- +97 other locations
EMPACT-MI: A Streamlined, Multicentre, Randomised, Parallel Group, Double-blind Placebo-controlled Superiority Trial to Evaluate the Effect of EMPAgliflozin on Hospitalisation for Heart Failure and Mortality in Patients With aCuTe Myocardial Infarction
This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to go to the hospital for heart failure and whether it lowers the chances of dying …
- 204 views
- 24 Oct, 2022
- +436 other locations